“A Scaffold-Aware Machine Learning Docking Pipeline for TYK2 Inhibitor Discovery with Calibrated Prioritization of 32 Active Compounds Including Deucravacitinib”, IRJMSS, vol. 6, no. 4, pp. 42–55, Dec. 2025, Accessed: Feb. 12, 2026. [Online]. Available: https://irjmss.com/index.php/irjmss/article/view/484